BCL2L11 and Parkinson disease: Wang et al. found that exogenous delivery of miR-124 could maintain the number of dopaminergic neurons and midbrain dopamine level in PD model via directly targeting and inhibiting Bim, a bcl-2 homology-3-only protein that exerts apoptosis-inactive and autophagy-inhibitory effects by reducing Bax translocation to mitochondria and lysosomal membrane under stimulation of methyl phenyl pyridinium (MPP) [23].